Gout Therapeutics Global Market Report 2025

Gout Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gout therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for gout therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gout therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Corticosteroid; Diuretics

2) By Treatment: Xanthine Oxidase Inhibitor; Uricosuria Medication

3) By Disease Condition: Acute; Chronic

4) By End-Users: Hospitals; Specialty Clinics; Other End Users

Subsegments:

1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Traditional NSAIDs; Selective COX-2 Inhibitors

2) By Corticosteroid: Oral Corticosteroids; Injectable Corticosteroids

3) By Diuretics: Thiazide Diuretics; Loop Diuretics

Companies Mentioned: Sanofi-Aventis; AstraZeneca plc; LG Chem Ltd.; GlaxoSmithKline Plc; Takeda Pharmaceuticals Co. Ltd.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. Gout Therapeutics Market Characteristics
3. Gout Therapeutics Market Trends And Strategies
4. Gout Therapeutics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market
5. Global Gout Therapeutics Growth Analysis And Strategic Analysis Framework
5.1. Global Gout Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Gout Therapeutics Market Growth Rate Analysis
5.4. Global Gout Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Gout Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Gout Therapeutics Total Addressable Market (TAM)
6. Gout Therapeutics Market Segmentation
6.1. Global Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Corticosteroid
Diuretics
6.2. Global Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Xanthine Oxidase Inhibitor
Uricosuria Medication
6.3. Global Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Acute
Chronic
6.4. Global Gout Therapeutics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Other End-Users
6.5. Global Gout Therapeutics Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Traditional NSAIDs
Selective COX-2 Inhibitors
6.6. Global Gout Therapeutics Market, Sub-Segmentation Of Corticosteroid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Corticosteroids
Injectable Corticosteroids
6.7. Global Gout Therapeutics Market, Sub-Segmentation Of Diuretics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Thiazide Diuretics
Loop Diuretics
7. Gout Therapeutics Market Regional And Country Analysis
7.1. Global Gout Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Gout Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Gout Therapeutics Market
8.1. Asia-Pacific Gout Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Gout Therapeutics Market
9.1. China Gout Therapeutics Market Overview
9.2. China Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Gout Therapeutics Market
10.1. India Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Gout Therapeutics Market
11.1. Japan Gout Therapeutics Market Overview
11.2. Japan Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Gout Therapeutics Market
12.1. Australia Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Gout Therapeutics Market
13.1. Indonesia Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Gout Therapeutics Market
14.1. South Korea Gout Therapeutics Market Overview
14.2. South Korea Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Gout Therapeutics Market
15.1. Western Europe Gout Therapeutics Market Overview
15.2. Western Europe Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Gout Therapeutics Market
16.1. UK Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Gout Therapeutics Market
17.1. Germany Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Gout Therapeutics Market
18.1. France Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Gout Therapeutics Market
19.1. Italy Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Gout Therapeutics Market
20.1. Spain Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Gout Therapeutics Market
21.1. Eastern Europe Gout Therapeutics Market Overview
21.2. Eastern Europe Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Gout Therapeutics Market
22.1. Russia Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Gout Therapeutics Market
23.1. North America Gout Therapeutics Market Overview
23.2. North America Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Gout Therapeutics Market
24.1. USA Gout Therapeutics Market Overview
24.2. USA Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Gout Therapeutics Market
25.1. Canada Gout Therapeutics Market Overview
25.2. Canada Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Gout Therapeutics Market
26.1. South America Gout Therapeutics Market Overview
26.2. South America Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Gout Therapeutics Market
27.1. Brazil Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Gout Therapeutics Market
28.1. Middle East Gout Therapeutics Market Overview
28.2. Middle East Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Gout Therapeutics Market
29.1. Africa Gout Therapeutics Market Overview
29.2. Africa Gout Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Gout Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Gout Therapeutics Market, Segmentation By Disease Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Gout Therapeutics Market Competitive Landscape And Company Profiles
30.1. Gout Therapeutics Market Competitive Landscape
30.2. Gout Therapeutics Market Company Profiles
30.2.1. Sanofi-Aventis Overview, Products and Services, Strategy and Financial Analysis
30.2.2. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
30.2.3. LG Chem Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Takeda Pharmaceuticals Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
31. Gout Therapeutics Market Other Major And Innovative Companies
31.1. Boehringer Ingelheim International GmbH
31.2. Regeneron Pharmaceuticals Inc.
31.3. Astellas Pharma Inc.
31.4. Sandoz
31.5. Eisai Co. Ltd.
31.6. Horizon Pharma Plc
31.7. Jiangsu HengRui Medicine Co. Ltd.
31.8. Hikma Pharmaceuticals plc
31.9. Swedish Orphan Biovitrum AB
31.10. JW Pharmaceutical Corp
31.11. Lannett Company Inc
31.12. BioCryst Pharmaceuticals Inc.
31.13. Selecta Biosciences Inc.
31.14. Rigel Pharmaceuticals Inc.
31.15. CymaBay Therapeutics Inc.
32. Global Gout Therapeutics Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Gout Therapeutics Market
34. Recent Developments In The Gout Therapeutics Market
35. Gout Therapeutics Market High Potential Countries, Segments and Strategies
35.1 Gout Therapeutics Market In 2029 - Countries Offering Most New Opportunities
35.2 Gout Therapeutics Market In 2029 - Segments Offering Most New Opportunities
35.3 Gout Therapeutics Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings